Newsfeeds - Spark Newswire

3 minute read

Sientra To Acquire AuraGen Aesthetic’s Fat Grafting Technology For Upfront Payment Of $1M In Cash And 3.9M Shares Of Stock; Agreement Includes Milestone Payments Of $3M Upon 12-Month Signing Anniversary And $8.5M Upon Endpoints

Today, 2:06 PM

Broadens Sientra’s opportunity within the estimated $13 billion U.S. plastic surgery market1 with the addition of a highly differentiated, FDA-cleared fat grafting technology Leverages Sientra’s

SIEN

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 2:06 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

1 minute read

FDA Restricts Sale, Approves New Labeling Of Breast Implants

By Vandana Singh

Today, 2:06 PM

The FDA is restricting the sale and distribution of breast implants over concerns about the risks of the devices, limiting…

ABBV

2 minute read

Earnings

Sientra’s Return On Capital Employed Insights

By Benzinga Insights

Today, 2:06 PM

According to Benzinga Pro data, during Q2, Sientra (NASDAQ:SIEN) posted sales of $20.10 million. Earnings were up 6.75%, but Sientra still reported an overall loss of $9.16 million.

SIEN

2 minute read

Sientra Highlights Study From Stanford University’s School Of Medicine

By Bill Haddad

Today, 2:06 PM

Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgery, today announced that a recent independent study out of Stanford

SIEN

1 minute read

Earnings

Sientra: Q2 Earnings Insights

By Benzinga Insights

Today, 2:06 PM

Shares of Sientra (NASDAQ:SIEN) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 52.94% year over year to ($0.32), which missed the estimate of ($0.22).

SIEN

1 minute read

Sientra Q2 EPS $(0.35) Misses $(0.22) Estimate, Sales $20.10M Miss $20.68M Estimate

By Benzinga Newsdesk

Today, 2:06 PM

Sientra (NASDAQ:SIEN) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.22) by 59.09 percent. This is a 48.53 percent increase over losses of $(0.68) per share from the

SIEN

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 2:06 PM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

9 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 2:06 PM

Before 10 a.m. ET on Friday, 115 companies hit new 52-week highs.

1 minute read

News

Sientra: Return On Capital Employed Insights

By Benzinga Insights

Today, 2:06 PM

Sientra (NASDAQ:SIEN) reported Q1 sales of $23.24 million. Earnings fell to a loss of $9.82 million, resulting in a 42.34% decrease from last quarter. In Q4, Sientra brought in $22.64 million in sales but lost $17.03 million in earnings.

SIEN